SARA SEXSON TEJTEL to Mucocutaneous Lymph Node Syndrome
This is a "connection" page, showing publications SARA SEXSON TEJTEL has written about Mucocutaneous Lymph Node Syndrome.
Connection Strength
1.303
-
Variability in Kawasaki Disease Practice Patterns: A Survey of Hospitalists at Pediatric Hospital Medicine 2017. Hosp Pediatr. 2019 09; 9(9):724-728.
Score: 0.620
-
Pediatric Thromboprophylaxis of Large Coronary Artery Aneurysm Using Rivaroxaban. J Pediatr Hematol Oncol. 2023 08 01; 45(6):356-359.
Score: 0.201
-
Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial. Lancet Child Adolesc Health. 2021 12; 5(12):852-861.
Score: 0.180
-
Comprehensive left ventricular myocardial deformation assessment in children with Kawasaki disease. Congenit Heart Dis. 2019 Nov; 14(6):1024-1031.
Score: 0.152
-
The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease. Contemp Clin Trials. 2019 04; 79:98-103.
Score: 0.150